Concepts (57)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| MAP Kinase Signaling System | 2 | 2022 | 302 | 0.290 |
Why?
|
| Megakaryocytes | 1 | 2025 | 40 | 0.220 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2025 | 148 | 0.200 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2022 | 13 | 0.180 |
Why?
|
| Pyrans | 1 | 2021 | 6 | 0.180 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2022 | 183 | 0.170 |
Why?
|
| src-Family Kinases | 1 | 2021 | 93 | 0.170 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2025 | 542 | 0.160 |
Why?
|
| Quinolines | 1 | 2021 | 117 | 0.160 |
Why?
|
| Dioxanes | 1 | 2019 | 3 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2021 | 617 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2019 | 106 | 0.150 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 137 | 0.150 |
Why?
|
| Thiazoles | 1 | 2019 | 113 | 0.150 |
Why?
|
| Biosensing Techniques | 1 | 2019 | 81 | 0.140 |
Why?
|
| Cell Differentiation | 1 | 2025 | 1912 | 0.130 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 1004 | 0.120 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 1319 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 978 | 0.120 |
Why?
|
| Melanoma | 1 | 2019 | 927 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 1813 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2593 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 3711 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2021 | 800 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2022 | 1569 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2025 | 345 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2022 | 34 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 124 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 112 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2022 | 143 | 0.040 |
Why?
|
| Germ Cells | 1 | 2022 | 201 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2021 | 311 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2022 | 312 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 553 | 0.040 |
Why?
|
| Cell Extracts | 1 | 2019 | 14 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2019 | 291 | 0.040 |
Why?
|
| Cysteine | 1 | 2019 | 137 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2019 | 126 | 0.040 |
Why?
|
| Peptides | 1 | 2022 | 707 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2025 | 1075 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2019 | 698 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1605 | 0.030 |
Why?
|
| Cell Movement | 1 | 2021 | 873 | 0.030 |
Why?
|
| Kinetics | 1 | 2019 | 1087 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2019 | 359 | 0.030 |
Why?
|
| Animals | 3 | 2025 | 33706 | 0.030 |
Why?
|
| Binding Sites | 1 | 2019 | 1134 | 0.030 |
Why?
|
| Mice | 2 | 2025 | 18182 | 0.030 |
Why?
|
| Protein Binding | 1 | 2019 | 1651 | 0.030 |
Why?
|
| Proteomics | 1 | 2019 | 616 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2021 | 2460 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2022 | 3812 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2022 | 1577 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 1825 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 2896 | 0.020 |
Why?
|
| Humans | 4 | 2022 | 130444 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 4662 | 0.020 |
Why?
|